Neuroscience 2002 Abstract
| Presentation Number: | 36.16 |
|---|---|
| Abstract Title: | THE AMPA RECEPTOR ANTAGONIST, E2007, AMELIORATES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE). |
| Authors: |
Smith, T.*1
; Yamauchi, T.2
; Groom, A. J.1
; Rivers, L.1
; Hanada, T.2
; Nishizawa, Y.2
; Yamamishi, Y.1
1Eisai London Res. Labs. Ltd., University College London, London, United Kingdom 2Eisai Tsukuba Res. Labs., Tsukuba, Ibaraki, Japan |
| Primary Theme and Topics |
Synaptic Transmission and Excitability - Neurotransmitters -- Glutamate |
| Session: |
36. Neurotransmitters: glutamate--disease mechanisms Poster |
| Presentation Time: | Sunday, November 3, 2002 11:00 AM-12:00 PM |
| Location: | Hall A2-B3 C-80 |
| Keywords: | MULTIPLE SCLEROSIS, NEUROPROTECTION, AXONAL PROTECTION, GLUTAMATE |
Damage to axons and neurons in multiple sclerosis (MS) is increasingly recognized as the major neuropathological correlate of disease progression. Currently, no adequate therapy is available for MS, despite immunomodulatory measures. The pathological and clinical features of MS can be reproduced in rodent models, collectively termed experimental autoimmune encephalomyelitis (EAE). Antagonists of the AMPA glutamate receptor, effective neuroprotectants, ameliorate EAE independently of immunosuppression [Nat. Med. (2000) 6:62-66; 6:67-70] suggesting either a neuro- and/or oligodendroglial-protective mechanism of action. Here, we describe the effect of a potent, water-soluble AMPA receptor antagonist, E2007 [profiled in Tokuhara et al and Hashizume et al SFN, 2002], on the course of EAE in Lewis rats [see also Yamauchi et al SFN, 2002]. E2007 (5, 10 and 20 mg/kg; p.o. 7-16 dpi) dose dependently improved neurological status without effecting CNS inflammation or peripheral MBP antibody production. Furthermore, the reduction in disease severity correlated with decreased axonal/neuronal damage (i.e. reversal in N-acetyl aspartate (NAA) loss and SMI-32 immunoreactivity). These results imply that therapeutic strategies for MS should be complemented by neuroprotective measures.
Sample Citation:
[Authors]. [Abstract Title]. Program No. XXX.XX. 2002 Neuroscience Meeting Planner. Orlando, FL: Society for Neuroscience, 2002. Online.
Copyright © 2002-2025 Society for Neuroscience; all rights reserved. Permission to republish any abstract or part of any abstract in any form must be obtained in writing by SfN office prior to publication.
